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Background: Two thirds of US women are not gaining the recommended weight 
during pregnancy (1) and 50% of women giving birth in the US are either overweight or 
obese (2). While little is known about the effect of gestational weight gain (GWG) on 
offspring cognition, previous research has shown that BMIs >24.9 may lead to impaired 
cognitive outcomes.  
Objective: To determine whether below or above recommended GWG has negative 
effects on cognition of the offspring and to determine whether pre-pregnancy BMI 
status affects offspring cognitive outcomes. 
Design: Pre-pregnant weight and GWG data were collected from a subset of women 
(n=221) enrolled in a phase III clinical trial from 2006-2010. The offspring of these 
women underwent habituation tests at ages 4, 6, and 9 months. We used both self-
reported pre-pregnancy weight and first clinic visit weight to determine GWG 
(inadequate, appropriate, or excessive) and weight status (normal or 
overweight/obese) categories. Underweight status was removed from data analysis 
due to few subjects in that category. All statistical analyses used mixed models.  
Results: When self-reported pre-pregnancy weight was used to calculate GWG, 
several statistically significant three way interactions were found. However, these 
interactions lacked validity due to small sample sizes. There was one statistically 
significant relationship between GWG category and percentage of looking in sustained 
attention (SA) (p-value: 0.047). No statistically significant results were found when 
GWG was calculated based on weight at the first clinic visit. 
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Conclusion: Women who gained weight appropriately during pregnancy had offspring 
with greater percentage of looking spent in SA. This finding suggests a more 
sophisticated level of information processing in infants of women who gained 
appropriately when compared to infants of women who gained inadequately or 
excessively. No clear associations were found between maternal weight status and 
offspring cognition in infancy. The effect of pre-pregnancy weight status may not 
manifest itself during infancy or be detectable on tests of habituation in infancy. If 
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BACKGROUND AND JUSTIFICATION 
In 2009 the Institute of Medicine (IOM) (currently the National Academy of 
Medicine)  published revised GWG guidelines (3). Previous GWG guidelines focused 
primarily on pregnancy outcomes such as gestational diabetes mellitus, preeclampsia, 
stillbirths, and other conditions (3). However, in addition to addressing pregnancy 
outcome, the new guidelines added long-term health outcomes of the offspring (i.e. 
asthma, obesity, and cognitive impairment) as a reason for appropriate GWG (3). 
Indeed the IOM specifically addressed neurodevelopment as an area potentially 
affected by GWG (3). This is surprising because in 2009 when the guidelines were 
published, no studies examining GWG’s effect on cognition of the offspring were 
available (3). The IOM recommended that more research be conducted. Since the 
publication of the 2009 guidelines seven studies have been published examining the 
effect of GWG on offspring cognition. Two of these studies were published on 
inadequate GWG and five on excessive GWG.  The published results of inadequate 
GWG on offspring cognition are conflicting. One study saw decreased cognitive 
functioning (4) while the other saw no significant results (5). The results of excessive 
GWG on offspring cognition were more in agreement. Four studies showed at least 
some negative effect of excessive GWG on offspring cognition (6-9) while one 





Statement of Purpose 
 The purpose of my thesis is to assess the correlation between GWG and infant 
cognition. In addition, I will examine the relationship between pre-pregnancy weight 
status and offspring cognition. I hope to determine whether the effect on offspring 
cognition of both GWG and weight status by Body Mass Index (BMI) manifest 
themselves at an early age. Additional research will help to improve the GWG 
guidelines further and determine the need for GWG interventions. Also, additional 
research could help reinforce the importance for women to reach a normal weight 
status before pregnancy onset and lend support for pre-pregnancy weight loss 
interventions    
Research Questions 
Primary research question 
 Is maternal GWG during singleton, full-term pregnancy related to early cognitive 
performance of the offspring as measured by attention at ages 4, 6, and 9 
months?  
Secondary research question 
 Is maternal weight status at the onset of pregnancy –normal weight or 
overweight/obese – related to early cognitive performance of the offspring as 












The IOM has established guidelines for inadequate, appropriate, and excessive 
GWG.  In 2009 the IOM updated the GWG guidelines. The guidelines recommended a 
range of weight gain based on pre-pregnancy weight status, determined by BMI. See 
table below (3).  






The IOM defined lower than recommended weight gain as “inadequate” and 
greater than recommended weight gain as “excessive”. To establish GWG guidelines, 
the IOM conducted research and identified areas in maternal and fetal health affected 
by weight gain. Offspring neurodevelopment was identified as an area potentially 
affected by GWG. The IOM stated that the effect of inadequate GWG on offspring 
cognition was especially of concern. However, it stressed that data were limited and 
more research be conducted on the effect of both inadequate and excessive GWG on 
offspring neurodevelopment. (3) 
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A limited amount of research exists regarding the impact of inadequate and 
excessive GWG on offspring cognition. However, additional research is needed to add 
to the body of literature to improve the weight gain guidelines further. Improved 
guidelines may help to prevent future GWG related offspring cognitive impairments. 
The purpose of this review of literature is to summarize the current knowledge on GWG 
and offspring cognition and to examine the need for further research. In addition, since 
maternal pre-pregnancy BMI is the determinant of GWG recommendations, I will also 
examine independently the effect of maternal BMI status on offspring cognition. 
Infant Habituation 
 Infant habitation is an early cognitive test that is based on the infant’s attention. 
Habituation tests are widely used to record perceptual and cognitive capabilities of 
infants (11). In a test of visual habituation, infant looking duration towards a stimulus is 
recorded. The stimulus is then repeatedly shown to the infant in a series of distinct 
trials. As the stimulus is repeatedly shown, looking time decreases. Decreased looking 
time indicates a decrease in the orienting reflex (a response to a nonthreatening but 
unfamiliar stimulus) (12). The decrease in attention shows that encoding and 
information processing to the stimulus have occurred. In combination with looking time, 
heart rate (HR) is commonly used to more precisely identify the distinct phases of 
looking (13, 14). The use of HR to measure habituation allows looking to be divided 
into distinct phases (15). The first phase is orienting (OR). During this phase, HR is 
accelerated and initial processing of the stimulus begins (16). The second phase is 
sustained attention (SA). This phase is characterized by decrease in HR and encoding 
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of the stimulus (16). The final phase of habituation is attention termination (AT). In the 
AT phase the look is sustained, however, HR decline has ended (16)  
 It should be noted that it was originally presumed that looking time decreased 
linearly throughout the first year. However, recently this has been shown not to be true. 
A review of literature by Colombo noted three distict phases (11). The first phase is an 
increase in brief looking between ages 8-10 weeks (17, 18), followed by a substantial 
decrease in looking time from that point until after 6 months of age (19, 20), and finally 
a plateau or slight increase subsequently through 12 months (21, 22).  
 While infant habituation has been studied for over 50 years and is widely used 
as a test of early cognition, its predictability is not well understood. The connection 
between infant cognition and later cognition is complex (23). It is noted that habituation 
is likely not in itself a component of intelligence but rather a “building block” for 
cognitive development during childhood (23).  
Inadequate GWG and Offspring Cognition 
In the 2009 guidelines, the IOM expressed concern for inadequate GWG and 
offspring neurodevelopment. The concern stemmed from previous data on the effect of 
ketonemia/ ketonuria (atypically high concentrations of acidic ketones in the blood/ 
urine) on offspring neurodevelopment as a result of maternal fasting or weight loss 
during pregnancy (3). Inadequate GWG can negatively affect cognition of the offspring. 
Gage et al.(4) conducted a large prospective cohort study in the United Kingdoms (UK) 
from 1990 until the  present to assess the relationship between GWG and academic 
achievement at ages 4, 8, and 16 years. The sample size was large (5,836 at 4 years; 
5,191 at 8 years, and 7,339 at16 years). Race/ethnicity was not specified. The results 
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of this study showed that inadequate GWG was associated with lower school entry 
exam scores at age 4 and decreased final exam scores at age 16 years (4). However, 
no significant results were found for IQ at age 8 on the Wechsler Intelligence Scale for 
Children (WISC). The strengths of this study include that it has a large sample size. 
Also, while it was conducted in the UK, it utilized the 2009 IOM GWG guidelines.  
 Hinkle et al.(5) also examined the effect of inadequate GWG on offspring IQ at 
age 5 years. The outcome measure was the Wechsler Preschool and Primary Scales 
of Intelligence Revised (WIPPSI-R). This prospective cohort study had a sample size of 
344. Women who were obese at pre-pregnancy were excluded from the study and 
82.3% of the women in the sample were normal weight. There were no significant 
effects of GWG after adjusting for covariates. The study sample was very narrowly 
defined (normal weight, Scandinavian woman). However, like the study by Gage et al, 
the IOM’s guidelines were used.  
 It should be noted that both Gage et al (age 8) and Hinkle et al. (age 5) used the 
same outcome measure, the WISC and both studies found no effect of inadequate 
GWG.  
Excessive GWG and Cognition 
 In addition to inadequate GWG, excessive GWG has been hypothesized to be 
associated with decreased cognitive functioning. However, the data are limited and, 
like inadequate GWG, most investigations have yielded null findings.  The effect of 
excessive GWG on cognition of the offspring at age 4 and 7 years was assessed in a 
large prospective cohort study by Keim et al. based in Columbus, Ohio between the 
years 1959 and 1973 (9). The sample size was 31,968 individuals, including 8,704 
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siblings and was equally divided between children of European and African descent. 
The cognitive tests performed were the Stanford-Binet Intelligence scale and Graham-
Ernhart Block Sort test at age 4 and the WISC and Wide Range Achievement Test 
(WRAT) at age 7 years. After adjusting for covariates, results were largely null except 
for one outcome in which excessive GWG was associated with a lower WRAT spelling 
test at age 7 years. Keim et al’s study (9) is notable because it was the first to assess 
GWG and offspring cognition using siblings as a reference to control for familial effects. 
The strengths of this study include the large and diverse sample, and sibling-paired 
model help to validate the outcomes.  
 Pugh et al. (7) recently published a study examining the relationship between 
excessive GWG and cognition of the offspring at ages 6, 10, and 14 years. The design 
was a prospective cohort conducted in Pittsburgh, PA between 1983 and 1986. The 
cohort was originally designed to examine the outcome of substance use during 
pregnancy. Women were included in the cohort if they either drank 3+ drinks of alcohol 
per week or smoked 2+ joints of marijuana per month during the first trimester. The 
sample sizes included 542 at age 6, 557 at age 10, and 468 at age 14; the sample was 
equally divided between African-American and Caucasian participants. The tests of 
cognition used were the WRAT-R test at age 6 and 10, The Stanford-Binet Intelligence 
Scale 4th edition and Child Behavior Checklist (CBCL) at age 10, and the Wechsler 
Individual Achievement Test (WIAT) at age 14. Excessive GWG was associated with 
decreased reading and spelling scores at ages 6, 10, and 14 years. The primary 
limitation of this study is that it was from a cohort with exposures that were potentially 
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problematic for cognitive function. While the effect of substance use was statistically 
accounted for as a confounder, it could diminish the strength of the results.  
The same cohort was used in two additional studies by Pugh et al. The first 
study’s aim was to assess the relationship between excessive GWG and Attention 
Deficit/Hyperactive Disorder (ADHD) at age 10 using the Conner’s Continuous 
Performance test, the CBCL, and teacher report forms (10).  The second study’s aim 
was to assess the relationship of excessive GWG on executive function and IQ at age 
10 (6). This study measured IQ using the Stanford-Binet Scale 4th edition and 
measured executive function using the Wisconsin Card Sort test and part B of the Trail 
Making test. The ADHD study yielded no significant results (10). The second study, 
however, did find a significant association.  While no association was found between 
GWG and IQ at10 years of age, excessive GWG was associated with decreased 
executive function at 10 years old.  
 The effect of maternal obesity and GWG on offspring IQ at age 7 years was 
studied by Huang et al (8). It should be noted, however, that the study was designed to 
determine the effect of pre-pregnancy BMI status on IQ rather than the effect of GWG. 
Thus, the methods and results on the effect of GWG on IQ are limited. Compared to 
the offspring of normal weight women who gained near optimal levels, the offspring of 
obese women who gained >40 lbs had a 6.5 point lower IQ (p<0.01). This is after 
controlling for the effect of obesity alone on IQ score. Also, normal weight women who 
gained between 21-25 lbs were used as a reference group during data analysis. This is 
the reason for the comparison made above. While this single result is interesting, the 
data analysis/ methodology on GWG and IQ should have been more complete. The 
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article presented an image showing the relationship between IQ and GWG. From 
looking at the plots it appeared that excessive GWG not only affects the obese sample, 
but other weight status categories as well, however, none of the statistical values were 
listed in the article.  
 Little is known about the effect of excessive GWG on offspring cognition and 
the available research has limitations. The three studies by Pugh et al (6, 7, 10) have a 
sample with many variables that could influence cognition adversely making 
interpretation of their results difficult and not necessarily generalizable. The research 
by Huang et al (8) focused on an obese population, also limiting generalizability. 
However, the study by Keim and Pruitt (9) had few limitations. It included a larger 
sample size and innovative statistical methods.  
Maternal Weight Status at Pregnancy Onset and Offspring Cognition 
 In addition to GWG, maternal weight status at pregnancy onset has also been 
shown to affect offspring cognition. While substantial literature exists on the impact of 
high maternal pre-pregnancy weight status and offspring cognition, little data exists 
assessing underweight status. Only two articles address the relationship between low 
maternal weight status at pregnancy onset and offspring cognition. 
 The first of these  was a secondary data analysis assessing the correlation 
between maternal pre-pregnancy BMI and offspring cognition at ages 5 and 7 years  
(24). The data for this study were obtained from a nationally representative prospective 
cohort study conducted in the UK (n=19,517). The outcome measures were subscales 
of the British Ability Scales second edition (BAS-II) at both 5 and 7 years and an 
additional number skills test at age 7. The results showed that being underweight (BMI 
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16-18.5 kg/m2), overweight (BMI 25-30 kg/m2), or obese (≥30 kg/m2) were all 
associated with decreased cognitive outcomes of the offspring at ages 5 and 7 year 
when compared to normal weight women (BMI 18.5-25 kg/m2). 
 The second article is a prospective cohort study conducted in the US examining 
the effect of maternal pre-pregnancy BMI on child neurodevelopment at 2 years of age 
(25). The sample is also nationally representative and made up of 6850 2-year-olds. 
The cognitive test performed was the Bayley Short Form-Research Edition. The results 
for this study were the same as the UK study. When compared with offspring of normal 
weight mothers, children with mothers who were underweight, overweight, or obese 
pre-pregnancy had lower scores on the Mental Development Index. 
 Unlike low maternal pre-pregnancy BMI, much research exists on the 
relationship between high maternal BMI’s and offspring cognition. Studies of high 
maternal BMI have examined effects based on, non-psychosocial and psychosocial 
cognitive outcomes. The non-psychosocial cognitive outcomes will be discussed first. 
 Three of these articles have been previously reviewed in this paper. The first is 
the study by Huang et al (8) which found that maternal obesity resulted in lower IQ 
scores at age 7. The results also showed that women with a BMI of 20 kg/m2 had 
offspring with the highest IQ scores. Pugh et al (7) found that there was an inverse 
relationship between academic achievement scores at ages 6, 10, and 14 years and 
pre-pregnancy BMI >22kg/m2., and in a second article (6) it was seen the maternal 
obesity was associated with a 3.2 point lower IQ score at age 10. 
 In addition to these articles, one additional study is worthy of discussion. A 
prospective cohort study examined the effect of maternal obesity on offspring cognition 
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between 60 and 83 months(26). The study was conducted in the US and had a sample 
size of 3,412 children. The cognitive test performed was the Peabody Individual 
Achievement Test (PIAT). The results showed a significant association between pre-
pregnancy obesity and lower PIAT scores that remained significant even after 
accounting for confounders (e.g., income and maternal education). 
 Psychosocial development has also been seen to be affected by high maternal 
weight status during pregnancy onset. The results of an article previously discussed by 
Pugh et al (10) showed that maternal obesity is correlated with increased offspring 
problem behaviors at age 10 years measured using the CBCL 
 Using data from a previous prospective cohort study, Jo et al (27) examined  
pre-pregnancy BMI status and child psychosocial development at age 6 years. The 
sample contained 1311 mother-child pairs. The cognitive test performed was the 
Strengths and Difficulties Questionnaire. The results showed that children of obese 
class I and II (BMI>35kg/m2) mothers had increased odds of emotional symptoms, peer 
problems, total psychosocial difficulties, ADHD diagnosis, autism, or developmental 
delay diagnosis and more often received special services when compared to normal 
weight women. 
 In an additional study, the effect of maternal pre-pregnancy BMI and child ADHD 
symptoms at age 6-8 years were examined (28). The study was a population based 
cohort study conducted in the US. A total 174 children were examined for ADHD 
symptoms using the CBCL. The results showed that children of obese mothers had 
significantly higher prevalence and severity of ADHD symptoms when compared to 
both overweight and normal weight mothers. In addition, the findings showed a 2.8-fold 
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increase in the prevalence of ADHD among children of obese mothers versus non-
obese mothers. 
 While there is a substantial amount of data on maternal pre-pregnancy obesity 
and offspring cognition, data for low maternal weight status is lacking.  
Conclusion 
Methods to assess infant cognition have been established and are widely used. 
Therefore, it is possible to assess the relationship between GWG/ pre-pregnancy 
weight and infant cognition. The limited available research shows either a null or 
positive correlation between inadequate or excessive GWG and offspring cognition. 
More research needs to be conducted to increase the knowledge on this topic. The 
data on maternal weight status at pregnancy onset and offspring cognition is also 
limited. While a substantial amount of literature exists on women who enter pregnancy 
while obese, little is available on those who enter pregnancy underweight. Further 
research will help to improve GWG recommendations to prevent future neurological 










Chapter 3  
METHODS 
Overview 
 The purpose of my thesis will be to assess the relationship between a) GWG  
and b) pre-pregnancy weight status on offspring cognition assessed by infant 
habituation at ages 4, 6, and 9 months. The proposed design is a secondary data 
analysis of the Kansas University Docosahexaenoic acid (DHA) Outcomes Study 
(KUDOS). Data on maternal GWG, pre-pregnancy weight, and infant attention has 
previously been collected at part of this study. KUDOS was a phase III randomized 
controlled trial (RCT) initiated in 2006 and conducted at the University of Kansas 
Medical Center. The primary KUDOS study was completed in two phases. The first 
phase of the trial compared two doses of DHA during pregnancy (600mg vs. 0mg) to 
gain knowledge about the safety and value of administration on pregnancy outcomes. 
The subjects who were in the intervention group were provided with 3 500-mg capsules 
containing a total of 600mgs of DHA, while the control group received 3 500-mg of 
placebo capsules filled with vegetable oil. Both groups were instructed to take the 3 
capsules daily from the enrollment until delivery. The second phase of the trial 
consisted of postnatal visits to examine the effect of maternal DHA supplementation on 
cognition and vision. Phase two had 5 postnatal visits between 4 and 18 months of age 
that assessed various behavioral outcomes.  
 The specific aims of the KUDOS study were to 1) determine whether RBC-
phospholipid- DHA can be significantly increased by supplementation 2) assess the 
effect of DHA supplementation on duration of gestation 3) evaluate adverse events in 
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women and infants in the treated and placebo groups 4) evaluate the effect of maternal 
DHA supplementation on visual evoked potential acuity in infancy and 5) evaluate the 
effect of DHA supplementation on the development of fundamental measures of 
cognitive function in infancy. I used data collected in both the first and second phases 
of KUDOS to examine the effect of GWG and pre-pregnancy weight status on offspring 
cognition. 
Sample 
 Woman were screened as eligible for KUDOS if they were between 16 - 35.99 
years old, English speaking, between 8 – 20 weeks gestation age, planning to deliver 
in the Kansas City metropolitan area, and had a telephone contact.  Women were 
excluded from the study if they were pregnant with multiple fetuses, had a BMI ≥ 40, 
diabetes mellitus, blood pressure ≥140 mm Hg, or other serious health conditions that 
were deemed likely to affect fetal development (i.e. HIV, hepatitis, and cancer).  
Research Setting 
 The study was conducted at the University of Kansas Medical Center. 
Participants were from the Kansas City metropolitan area and were recruited at the 
obstetrics clinics at the University of Kansas Medical Center (Kansas City, KS), 
Truman Medical Center (Kansas City, MO), and St. Luke’s Hospital (Kansas City, KS). 
The study enrolled participants between January 2006 and November 2009. Women 
were screened as eligible (2188) and 350 consented to be enrolled in the study. Of this 
350, 301 participants completed the study through delivery. From the 301 women who 
delivered, 158 of the offspring completed 4 month visits, 170 completed 6 month visits, 
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and 156 completed 9 month visits. All postnatal follow-up visits were conducted at the 
University of Kansas Medical Center. 
Ethics 
 The Human Subjects Committee (HSC#10186) at the University of Kansas 
Medical Center approved this study. All participants completed an informed consent 
form at enrollment (see Appendix A). Research and the informed consent protocol 
complied with the Declaration of Helsinki and were approved by the Institutional 
Review Boards and Human Subjects Committees at The University of Kansas Medical 
Center (Kansas City, KS); the University of Missouri – Kansas (Truman Medical 
Center); and St. Luke’s Hospital (Kansas City, MO). All participants were informed 
about their privacy protection under the Health Insurance Portability and Accountability 
Act (HIPPA). All members of the research team followed university confidentiality 
policies, Privacy Protection for Research Subjects, and held certification with NIH 
Human Subjects protection and HIPPA. All participant data was stored in a secure 
location, accessible only by research personnel.  Participants were given a random 
identification number at enrollment. This number along with the mother’s initials was 
used for identification of the offspring during postnatal visits to maintain confidentiality 
of the participants. 
Procedures 
 This study design is a retrospective cohort study using secondary data analysis 
of data obtained in the KUDOS trial. The purpose is to assess the possible association 
between GWG and pre-pregnancy weight status on cognition of the offspring.  
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 Pre-pregnancy and full-term maternal weights were previously collected as part 
of the KUDOS study. Pre-pregnancy weight status was obtained both through medical 
records documenting weight at first OB appointment and through self-reported pre-
pregnancy weight at enrollment. Full-term pregnancy weight was obtained using last 
recorded weight prior to delivery found in medical records. First appointment weight 
was used to determine both pre-pregnancy BMI status and to calculate GWG. 
 After delivery the infants returned for postnatal visits at 6 weeks, and 4, 6, 9, 10, 
and 18 months. Trained personnel performed Infant habituation tests at visits 4, 6, and 
9 months. During this test, the infants were seated in a darkened quiet room and 
shown images of adult human faces on a screen. The phases of looking [orienting 
(OR), sustained attention (SA), and attention termination (AT)] were measured. In 
addition, peak look, total look duration, average looking time, and trials to habituation 
were recorded. Heart rate was measured along with looking to more clearly identify 
each phase of attention. The stimulus was repeatedly shown to the infant. Overtime, 
the infant’s look duration began to decrease indicating encoding/learning had taken 
place. All tests of infant habituation were video recorded. The videos were later coded 
by two trained observers to distinguish the phases of looking and amount of time spent 
in each phase. Heart rate was used to assess the quality of attention during looking. 
During habituation, events such as infant fussiness, parental interference, and 
mechanical errors made some of the data unusable: 76% of the data at 4 months, 87% 





Analysis of Data 
 GWG was calculated is two ways, using first clinic weight and using self-
reported pre-pregnancy weight. The two GWG values were compared as mean ± SD, 
while minimum and maximum values are also reported. GWG was analyzed as a 
categorical variable (using IOM guidelines). Pre-pregnancy weight status was analyzed 
as a categorical variable using 3 of the 4 weight status categories (normal, overweight, 
and obese). The underweight category was excluded from data analysis due to the 
sample being small (n=3 for 1st clinic visit weight and n=7 for self-reported weight). 
Infant gender and age were used as fixed effects during data analysis. Looking times 
were analyzed using both proportion and amount of time spent in each category. In 
addition, peak look, average looking, and total looking were analyzed. Mixed models 
method was used for all statistical analysis comparing either GWG or pre-pregnancy 
weight status to looking times. Differences with caregiver Peabody Picture Vocabulary 
Test (PPVT) scores, and maternal DHA supplementation were confounded. Smoking 
status during pregnancy, maternal age, and race were found to have no effect on 
offspring looking, and were not included in the model as covariates.  All data was 
analyzed with SPSS Statistical 22.0 software. Data was considered significant if p-




Chapter 4  
RESULTS 
Subject Characteristics 
 Of the 350 women who were enrolled in the KUDOS study a subset 221 women 
were evaluated to assess the possible association between GWG and pre-pregnancy 
weight status on infant cognition. Women were included in the subset if their offspring 
attended at least one of the study visits at 4, 6, and 9 months. See TABLE 1 for a 
summary of maternal characteristics and TABLE 2 showing both self-reported and first 
clinic visit weights of the mothers.  
Table 1 
  TABLE 1. Summary of Maternal Characteristics ¹     
  Mean ± SD Min - Max 
  Race (%white / %black / %other) 68/30/2   
  Age at enrollment (y) 26.08 ± 4.74 16.06 - 35.97 
  PPVT 99.38 ± 15.15 67-140 
  Smoking during pregnancy (%n/%y) 65/35   
  
¹Two hundred and twenty-one values for race, age, and smoking status. Two hundred and ten PPVTs 













  TABLE 2. Comparison of Self-Reported and First Clinic Visit Weights   
  Mean ± SD Min - Max 
  BMI Category (%)¹     
  Self-Reported 4/46/31/19   
  First Clinic Visit 1/35/35/29   
  BMI Self-Reported (kg/m²) 25.66 ± 4.99 15.1 - 39.96 
  BMI First Clinic Visit (kg/m²) 27.2 ± 5.19 16.53 - 42.56 
  GWG Category (%)2     
  Self-Reported 9/23/68   
  First Clinic Visit 21/29/49   
  GWG Self-Reported (lbs) 37.64 ± 15.44 -13 - 93 
  GWG First Clinic Visit (lbs) 28.52 ± 12.59 -6 - 59 
  ¹Underweight/normal/overweight/obese     
  ²Inadequate/appropriate/excessive GWG    
 
GWG and Cognition 
 Using self-reported pre-pregnancy weight, we found a statistically significant 
relationship between proportion of looking in SA and GWG (P-value: 0.047). See 
FIGURE 1. The proportion of looking in SA reflects the amount of time actively 
engaging in learning and information processing of the stimulus. This analysis 
averaged SA in each GWG category across all 3 ages tested (4, 6 and 9 months). As 
part of normal development, the percentage of looking spent in SA commonly 
decreases as the infant ages. However, it should be noted that SA maintenance 
throughout the first year of life has been associated with increased cognitive outcomes 
during childhood (29) We did not find an interaction between infant age and GWG 
category (p-value: 0.780). No other significant or near significant results were seen 
between GWG and offspring cognition.  
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No significant associations were found between GWG and infant looking at 4, 6, 
or 9 months when using first clinic visit weight. 
Pre-pregnancy BMI and Cognition 
 When using self-reported weight to determine weight status before pregnancy, 
several three-way interactions were seen. However, these results are invalid due to 
small cell sizes.   
 No significant association was observed between pre-pregnancy weight status 






















GWG and Cognition 
 According to the 2015 national vital statistics report of birth data, it is estimated 
that 48% of women gain excessively, 32% gain appropriately, and 21% gain 
inadequately (1). Compared with the national average, the women in this study had 
similar GWG values. When calculated using self-reported pre-pregnancy weight, 68% 
gained excessively, 23% gained appropriately, and 9% gained inadequately.  Based on 
their weight at the first clinic visit, 49% gained excessively, 29% gained appropriately, 
and 21% gained inadequately.  With at least two-thirds of pregnant women not gaining 
the recommended amount of weight, this is a public health concern.  
 Previous research has shown that either excessive or inadequate GWG may 
affect cognition of the offspring (4, 6-9). However, all prior studies examined the effect 
of GWG on cognition at an older age of the offspring. In this study, when examining the 
effect of GWG on offspring cognition during infancy, only one association was found. It 
was seen that women who gained appropriately during pregnancy had offspring with a 
greater percentage of looking in SA (p-value: 0.047). This association was seen only 
when GWG was calculated using self-reported weight, but not when using first clinic 
visit weight. While one might question the reliability of self-reported  pre-pregnancy 
weight, almost all previous research studying the impact of GWG or maternal BMI 
status on offspring cognition have used self-reported weights. Using self-reported 
weight seems to be standard. The only exception I found was Buss et all (28) who 
used first clinic visit weight. Because women were enrolled between 2 and 5 months of 
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pregnancy, the use of weight at the first clinic visit should have resulted in a highly 
variable GWG between the onset of pregnancy and first clinic visit among the subjects. 
Even though only one variable was found to be significantly related to GWG, it 
should be noted that proportion of looking in SA attention is a main variable of interest 
when analyzing habituation data. Proportion of looking in SA reflects the amount of 
time actively engaging in learning and information processing of the stimulus. It 
appears that the effect of GWG on cognition may manifest itself during infancy. 
Pre-pregnancy BMI and Cognition 
 According to the 2014 national vital statistics report, approximately 3.8% of 
women who gave birth in the US were underweight, 45.9% were normal weight, 25.6% 
were overweight, and 24.8% were obese (2). Thus, one in every two women who 
delivers in the US is either overweight or obese. Also, the number of overweight and 
obese women in the US is likely increasing (30). When using self-reported weight 4%  
of our subjects were underweight, 46% were normal weight, 31% were overweight, and 
19% were obese. In comparison, using the first clinic visit weight,1% were 
underweight, 35% were normal, 35% were overweight, and 29% were obese. The 
proportions using self-report are more closely aligned with national statistics, 
suggesting that self-report is a better representation of weight status at the start of 
pregnancy. 
 The research shows consistent evidence that obesity negatively effects offspring 
cognition (6-8, 24-28), however, as noted previously the studies have been done in 
populations with little overweight/obesity and the literature is weighted heavily toward a 
group of subjects considered at risk for drug and alcohol use. However, little is known 
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about the effect of being underweight (24, 25). Due to the evidence supporting the 
association between obesity and decreased cognition, I hypothesized that there would 
be a significant association between obesity and infant attention. However, our results 
do not support a link between weight status and infant cognition. In addition, due to the 
large amount and strength of previous research showing the negative connection 
between obesity and offspring cognition, I question whether little association truly 
exists or whether the observed effect on cognition is not able to be seen until a later 
age. The effects of maternal pre-pregnancy BMI may not manifest itself during infancy. 
Thus, infant attention tests may not be suitable for this study.  
 There were several statistically significant three way interactions found for 
weight status and infant attention, but no clear connection was seen. This could be due 
to the fact that subgroups were very small when divided by GWG and gender. Results 
were only seen when self-reported weights were used, but not first clinic visit weight. 
As discussed above, self-reported weight is more in line with national statistics for 
weight status at the beginning of pregnancy, however, it would be preferable to have a 
measured weight at the start of pregnancy.  
More research does seem worthwhile using infant attention as an outcome.  
There will also be the opportunity to explore these issues at older ages, because we 
have age-appropriate cognitive assessments out to 6 years of age. 
Further Research  
 While few conclusive results were found during this study, further research 
should be conducted to assess both the effect of GWG and pre-pregnancy BMI on 
cognition. I recommend that GWG and weight status be explored in relation to 
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measures of cognition that have been obtained on this cohort up to age 6 years. With 
such a high prevalence of excessive GWG and overweight/obese status, it is important 
to determine if there are negative effects on offspring cognition.  
Limitations 
 Both self-reported weight and first clinic visit weight were used for data analysis. 
Due to a large variation in the gestation age (GA) at first clinic visit, it is likely that first 
clinic visit weights are not an accurate measure of GWG. The GA at first visit ranged 
from 4 weeks – 23 weeks with a mean of 11 weeks and standard deviation of 3.85. 
Due to an estimated optimal weight gain of 1lb/wk after week 13, this would likely 
underestimate weight gain of those participants who had their first clinic visit during 
their second trimester. On the other hand, self-reported weight is likely a limitation, 
because it is common for individuals to underestimate their weight. A further limitation 
is that we could not use self-reported weight in all cases and had to use first clinic 
weights for 29 (13% of total women) because some women could not recall a pre-
pregnancy weight.  
 This is the first study, to my knowledge, to assess the association between 
GWG and pre-pregnancy weight status on infant cognition. All previous research has 
assessed either child or adolescent cognition. Thus, we are unable to compare the 
results of this study to the work of other researchers. 
 Due to such a small sample of underweight women (n=7 for self-report and n=3 
for first clinic visit) in our cohort, data analysis was not possible in that BMI group.    






 With estimates of only one third of US women gaining recommended weight 
during pregnancy (1) and 50% of pregnant women being overweight or obese (2), it 
becomes a public health concern. While this study found little significant relationship 
between GWG or pre-pregnancy BMI on offspring cognition, previous research has 
observed significant findings of obesity on cognitive outcomes. The effects of GWG 
and pre-pregnancy BMI may not manifest themselves during infancy or be able to be 
detected on tests of habituation.  
 Future research to evaluate the effect of GWG and pre-pregnancy weight status 
should be conducted using cognitive outcomes assessed from 18 months to 6 years 
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CONSENT  FORM 
The Effects of DHA on Pregnancy and Infant 
Outcome (Kansas  University  DHA Outcomes  
Study or  KUDOS) 
 




As a pregnant woman who is between 8 and 20 weeks of gestation, you are 
being invited to enroll in a research study of a nutrient (DHA) that is a component 
of normal brain and important for brain development. The centers involved in the  
study are the University of Kansas Medical Center in Kansas City, Kansas, St. 
Luke's Hospital in Kansas City Missouri, and Truman Medical Center in Kansas 
City, Missouri. If you decide to enroll in this study, your baby will participate in 
research procedures at the University of Kansas Medical Center. Dr. Susan 
Carlson is the main investigator for this study. A total of 350 pregnant women will 
be enrolled in this study between October 2005 and January 2010. 
 
You do not have to participate in this research study. It is important that before 
you make a decision to participate, you read the rest of this form. You should 
ask as many questions as you need to understand what will happen if you 
participate in the study. 
BACKGROUND 
Docosahexaenoic acid (DHA) is a fat that is found in very large amounts in the 
brain. DHA is important for how my baby sees and learns. Breast milk and, since 
2002,  US formulas contain DHA. Many studies have shown that DHA in the diet 
helps the baby's  vision, attention, and ability to learn. In this way, DHA is 
considered an important nutrient for babies after they are born. 
 
DHA may also be important before  babies  are  born. Four studies found that 
women's  DHA during pregnancy was related to  higher  infant/child  function.  
These  studies  are  called observational studies, meaning that the women's 
normal DHA status was studied in relation to development of the baby/child. 
There is only one study that gave women DHA  during pregnancy and measured 
development of their babies/children. That study showed higher IQ at 4 years of 
age in children whose mothers took fish oil capsules during the last 6 months of 
pregnancy. (Fish oil contains a lot of DHA). However, because women  in the  
study also consumed DHA while they were breastfeeding they provided more 
DHA to their  babies after they were born. Therefore, the study does not prove 
that giving DHA before babies are born will help their development. There are 
no studies that have varied DHA  intake only during pregnancy. You and your 





The purpose of this study is to determine if a dietary supplement of DHA during 
pregnancy will help babies be born at the right time and help their development. 
If you decide to be in the study, you will have a 50-50 chance of receiving 
capsules with the supplement of DHA or ordinary food oil, which does not contain 
any DHA. 
PROCEDURES 
If you choose to enroll yourself and your infant in this study, the investigators will 
record some information from your medical record about your pregnancy and 
medical history. They will also ask you a few questions about foods that you 
usually eat.  You will have a blood sample collected from a vein in your arm.  
One-half teaspoon of blood will be drawn. The blood will be used to measure 
DHA in your blood as well as other nutrients.  You will be asked to provide a 
current address and phone number where you can be contacted.  . 
 
During pregnancy: You will be randomly assigned (like flipping a coin) to 
capsules with DHA-oil or ordinary food oil (which does not contain any DHA). 
The DHA-oil is the same oil that is used in US infant formulas and has been fed 
safely to millions of infants. 
 
You will be given enough capsules each month to take 3 capsules each day and 
you agree to try to consume all 3 capsules. If you consume all 3 capsules, you 
will consume 600 mg of DHA. The capsules are relatively small and you should 
find them easier to swallow than many nutrient supplements. They are orange-
flavored, so if you burp (common in pregnancy and in the first week of taking any 
nutrient supplement), the taste should not be unpleasant. You do not need to 
take the capsules at any specific time as they are a nutrient and not a drug. 
However, you should decide upon a regular time to take them so that taking  the 
capsules will become a habit and you won't forget. For example, you might wish to 
take them just before you go to bed or when you have your first beverage of the 
day. 
 
Neither you nor the investigators will know which capsules you have been 
assigned to. On the day you enroll for the study, we will send you home with 
your first bottle of capsules. About 30 days later (early enough so that you do 
not run out of capsule), you will receive another bottle of capsules in the mail. 
AT THAT TIME, YOU AGREE TO PLACE THE FIRST BOTTLE WITH ANY 
REMAINING CAPSULES IN THE ENVELOPE AND DROP IT INTO THE MAIL. 
 
This process will be repeated each month until your baby is born and you will 
continue to take 3 capsules per day until your baby is born. Each time you 
receive a new bottle, you will mail back the bottle that you have been using and 






The investigators will contact you by phone at least once per month. They will 
ask about capsule intake and they will ask how you are doing. Maintaining contact 
with our study personnel on a monthly basis is very important. 
 
IF YOUR PHONE NUMBER OR ADDRESS CHANGES AT ANY TIME DURING 
THE STUDY, YOU WILL LET THE INVESTIGATORS KNOW BY CALLING 913-
588-3781 AND LEAVING A MESSAGE. 
 
Delivery: After you are admitted to the hospital to deliver, you should telephone 
study personnel or ask the person at admitting to telephone them. You will be 
given a cell phone number today to call. Once you deliver your baby, the 
investigators will visit you in the hospital to collect data about your delivery and 
your baby's health. A sample of your baby's cord  blood  will  be  collected  after  
delivery  by  nurses  at  the  hospital  and  given  to  the investigators. A nurse will 
also draw a small blood sample (one-half teaspoon) from you while you are in 
the hospital. The blood samples will be used to measure DHA and other 
nutrients. The investigators will visit you, and give you an appointment for your 
baby's first follow-up visit at KUMC. 
 
Visit 1 (6 weeks of age): The investigators will measure how your baby sees 
using a test that involves placing 3 electrodes directly on your baby's head. The 
process involves cleaning the area then placing a small amount of paste similar 
to toothpaste on the head. The electrodes are placed on top of the paste. The 
electrodes will be used to record your baby's brain waves while he/she is looking 
at pictures. Your child's weight, height and head circumference will be measured 
again and you will be asked questions about what your baby eats. If you are 
breastfeeding your baby, you will be asked to provide a teaspoon of breast milk 
to the investigator. The sample will be frozen and analyzed for fats that are found 
in the capsules. The visit should last about 40 minutes. You should arrive on 
time and allow that amount of time for the visit. 
 
Visit 2 (4 months of age): The investigators will measure how your baby sees 
using the same test as before and another vision test. Your baby will wear a 
pair of plastic glasses during the second test. In another test, your child will be 
given an object to look at several times. The investigator will measure how long 
he/she looks at the object and how quickly he/she stops looking at the object. 
Your  child will be video recorded during the test. Your baby's heart rate will be 
measured during the test. Your baby's height, weight and head circumference will 
be measured and you will be asked about what food your baby eats. Your baby 
will have a blood sample collected by either heel stick or drawn from a vein. If 
it is necessary to use a heel stick, the investigator may use a cream or spray 
that will numb the area before obtaining the sample. One-half teaspoon of blood 
will be drawn. The blood will be used to measure DHA and other nutrients. You 
should let the investigator know if your baby has been sick or not acting well 
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since his/her last visit. The visit will take 60-90 minutes. 
 
Visit 3 (6 months of age): The investigators will measure how your baby sees 
using the test that requires him/her to wear a pair of plastic glasses. In another 
test, he/she will be given an object to look at several times Oust like at 4 months 
of age). The investigator will measure how long he/she looks at the object and 
how quickly he/she stops looking at the object. Your child will be video recorded 
during the test. Your baby's heart rate will be measured during the test. Your 
baby's height, weight and head circumference will be measured. You will be 
asked questions about what your baby eats. You should let the investigator 
know if your baby has been sick or not acting well since his/her last visit. The 
visit should take 40 -60 minutes. 
 
Visit 4 (9 months of age): Your baby will have both tests that measure how 
he/she sees. In another test, your child will be given an object to look at several 
times Oust like at 4 and 6 months of age). The investigator will measure how 
long he/she looks at the object and how quickly he/she stops looking at the object 
and your baby's heart rate will be measured during the test. Your  child will be 
video recorded during the test. Your  baby's height, weight and head 
circumference will be measured. You will be asked questions about what your 
baby eats. You should let the investigator know if your baby has been sick or not 
acting well since his/her last visit. The visit should take about 40-60 minute
 
Visit 5 (10 months of age): During this visit your baby will be placed on your lap 
in front of a small table. A test will be completed with a small toy, foam block 
and 2 cloths that will be placed in front of your child. You will also take a short 
language test. The small toy will be given to your child to keep. In another test, 
your baby will be asked to take turns with the researcher building fun toys. After 
your baby has played for a moment with the pieces, the researcher will show 
him or her how to build the toy. Then, your baby will be given a turn to put the 
toy together. Your baby's turn will happen either in:imediately or after 10-minutes 
of play with other things. We will show your child objects in groups of 2 and 3 to 
see how long they look at the objects. Your child will be video recorded during the 
tests. You should let the investigator know if your baby has been sick or not acting 
well since his/her last visit. You will be asked questions about what your baby 
eats. The entire 10-month visit should last 70 minutes. 
 
Visit 6 (12 months of age): The investigators will measure how your baby sees 
using both vision tests. Your child will be video recorded while playing with an 
interesting toy and the investigator will use the recording to measure some 
aspects of attention. We will show your child objects in groups of 2 and 3 to see 
how long they look at the objects. Your child's height, weight and head 
circumference will be measured. You will be asked questions about what your 
baby eats. You should let the investigator know if your child has been sick or not 
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acting well since his/her last visit. We will request your child's medical record 
from his/her doctor. The visit should take about 2 hours. It is important that your 
child be rested before the testing at this visit. If for some reason your baby 
cannot finish the tests that day - this may happen if he/she is unusually fussy or 
tired - you will be asked to return to finish the remaining tests within 7 days. 
 
Visit 7 (18 months of age): The investigators will measure how your child sees 
using the test that he/she had while wearing plastic glasses. Your child will be 
video recorded while playing with an interesting toy and the investigator will use 
the recording to measure some aspects of attention. Your child will also be given 
a standardized test to measure mental and physical development. Your child's 
height, weight and head circumference will be measured. You will be asked 
questions about what your baby eats. You will be asked questions about the 
words your child uses and understands. You should let the investigator  know if 
your child has been sick or not acting well since his/her last visit. The visit 
should take about 2 hours. It is important that your child be rested before the 
testing at this visit. If for some reason your child cannot finish the tests that day 
- this may happen if he/she is unusually fussy or tired - you will be asked to 
return to finish the remaining tests within 7 days. 
 
RISKS 
Some redness, soreness, or bruising may occur at the site of blood sampling. 
There is also a very slight risk of infection. 
 
You may experience burping from the capsules and find this unpleasant 
 
There are no known risks of consuming the amount of DHA you will be provided if 
you receive the DHA. Even if you forget to take your capsules for one or two 
days, there is no known risk of deciding to "catch up" on the third day. The 
amount is smaller than pregnant
 
women in many countries eat every day. Nevertheless, you could develop a 
problem that has not been observed before. 
 
NEW FINDINGS STATEMENT 
You will be informed if any significant new findings develop during the course of 
the study that may affect your willingness to participate or to allow your child to 
participate in this study. 
 
BENEFITS 
You and your child may or may not benefit from participating in this study. If you 
receive the supplement, it may help your baby to be born at the right time and 
your baby's/child's development. If you will not get the supplement, your baby and 
you will not be getting any of those benefits. It is also possible that all 
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infants/children will get some benefit from  being followed closely with 
developmental testing. It is hoped that additional information gained in this 
research study may be useful in understanding if DHA can help your baby be born 
at the right time and help your baby's vision, attention, and learning as he or 
she grows. You will receive a video recording of your infant doing the 4, 6, and 9 
month looking test when the 12 month visit is complete 
ALTERNATIVES 
You do not have to participate in this study to be able to take DHA supplements 
while you are pregnant. You may purchase capsules containing DHA at local 
stores without a prescription (for example, Osco, Costco, Wal-Mart). There are 
also several brands of prenatal supplements with DHA available by prescription 
or over the counter. The prenatal capsules typically contain 200 mg of DHA each 
and are marketed to take one capsule/day as a DHA supplement. 
 
COSTS 
Capsules containing either DHA or food oil will be provided to you at no cost 
while you are participating in this study. You will not incur any costs because of 
your or your child's participation 
 
PAYMENT TO SUBJECTS 
If study investigators are able to communicate with you each month you will be 
given 2 bonus gift cards to either Wal-Mart or Target of $25 each. The first gift 
card will be given to you half way through your treatment phase if communication 
is maintained at least one time each month during the first half of your treatment. 
The second gift card will be given at delivery if communication maintained at least 
one time each month during the second half of your treatment. 
 
Additionally, if the study investigators are called after you are admitted for delivery 
you will be given your choice of a bonus gift card worth $50 from either Wal-
Mart or Target. You may make the call yourself or have someone else call for 
you. Study personnel will give you the gift card when they come to the hospital 
after your baby is born. 
 
Once your baby is born,you will receive a check for $50 after your baby 
completes each of the following visits: 6 weeks, 4 months, 6 months, 9 months, 
and 10 months. You will receive a check for $100 after your child completes 
each of the following visits: 12 and 18 months. 
 
The reimbursements are to cover the costs of transportation and to partially 
compensate you for your time required to participate in the study. 
 
Your IOMe, address, social security number, and the title of this study will be 
given to the KUMC Research Institute. This is done so that the Research 




I N THE EVENT OF I NJURY 
In the event you experience any serious health problem (hospitalization, life-
threatening illness,  or  death)  for   any   reason  during  your  pregnancy,  you  
should  immediately  seek treatment or help in the way you normally would as if 
you were not in a study. You should let Susan Carlson, Ph.D. know about any of 
these problems as soon as possible by calling her office (913-588-5359) or the 
study office  (913-588-3781 ). A  message may be  left at  both numbers.  Dr. 
Carlson may also be reached at home (816-960-1805). 
 
I NSTITUTIONAL DISCLAIMER STATEMENT 
If you believe you have been injured as a result of participating in research at 
Kansas University Medical Center (KUMC), you should contact the Director, 
Human Research Protection Program, Mail Stop #1032, University of Kansas 
Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160. Compensation to 
persons who are injured as a result of participating in research at KUMC may 
be available, under certain conditions, as determined by state law or the Kansas 
Tort Claims Act. 
 
Truman Medical Center (TMC) will provide medical attention to you if you suffer 
any injury or harm as a direct result of participating in this research project. TMC, 
your study doctor, and the sponsor of this study will decide, at their discretion, 
who should pay for the medical care. TMC will provide treatment to you in the 
event of any medical emergency while present at TMC, whatever the cause. 
Moreover, you will have the benefit of the coverage of any existing healthy 
insurance you own. Participation in this research study does r:iot take the place 
of routine physical examinations or clinic visits to your person physician. If you 
believe you have been injured as a result of participating in this study you are 
encouraged to contact the study investigator, Dr. Susan Carlson, at her work 
number, 913-588-5359. 
 
The University of Missouri-Kansas City appreciates the participation of people 
who help it carry out its function of developing knowledge through research. 
Although it is not the University's policy to compensate or provide medical 
treatment for persons who participate in studies, if you think you have been 
injured as a result of participating in this study, please call the investigator, Dr. 
Susan Carlson at 913-588-5359 (work) or Sheila Anderman, IRB administrator of 
UMKC's Adult Health Sciences Institutional Review Board at 816-235-6150 
 
CONFIDENTIALITY AND  PRIVACY AUTHORI ZATION 
IOMes of subjects or information identifying subjects will not be released without 
written permission unless required by law. Videotapes of your baby when he/she 
is looking  at pictures and playing with toys will be used only by the investigators 
and their students and to make a videotape copy for you. The videotapes will be 
secured under lock and key like all other information that could be linked directly 
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to your child. The videotape of your child will not be shown without  specific 
permission from you and even then would  not identify your 
 
child by IOMe. Efforts will be made to keep you and your child's personal 
information confidential. Researchers cannot guarantee absolute confidentiality. If 
the  results of this study are published or presented in public, information that 
identifies you and/or your baby will be removed. 
 
The privacy of you and your child's health information is protected by a federal 
law known as the Health Insurance Portability and Accountability At (HIPAA).  If 
you choose to participate in this study, you will be asked to give permission for 
researchers to use and disclose your and your baby's health information that is 
relevant to the study. 
 
To perform this study, researchers will collect health information about me and my 
child from his/her and my medical records and from the study activities that are 
listed in the Procedures section of this consent form. My and my baby's study-
related health information will be used at KU Medical Center by Dr. Carlson, 
members of the research team,  Truman  Medical Center, St. Luke's Hospital and 
the KU Hospital Medical Record Department, the KUMC Research Institute and 
officials ·at KUMC and at Truman Medical Center that oversee research, including 
the KUMC Human Subjects Committee, the IRB that governs St. Luke's Medical 
Center and Truman Medical Center and other committees  and offices that 
review and monitor research studies. 
 
Dr. Carlson and her team may share information about me and my baby with 
representatives of Martek Biosciences, the monitoring company who verifies 
study data, the laboratory that processes study lab samples, other business 
partners who help with the study, the U.S. Food and Drug Administration (FDA), 
and U.S. agencies that govern human research (if and when regulatory 
compliance issues arise). Martek Biosciences (Columbia,  MD) donated the 
capsules for this study that is otherwise supported by the National Institute of 
Child Health and Human Development. 
 
Some of the persons or groups that receive my and my baby's study information 
may not be required to comply with HIPAA privacy laws. My and my child's 
information may lose its federal protection if those persons or groups disclose it. 
 
Permission granted on this date to use and disclose my health information 
remains in effect indefinitely. By signing this form I give permission for the use 
and disclosure of my and my child's information for purposes of the study at any 
time in the future. 
 
If I enroll in the study, the investigators cannot tell me what capsule I was 






I have read the information in this form. Dr. Carlson or her associates have 
answered my question(s) to my satisfaction. I know if I have any more questions 
after signing this I may contact Dr. Carlson or one of her associates at (913) 
588-5359. If I have any questions about my or my child's rights as a research 
subject, I may call (913) 588-1240 or write the Human Subjects Committee, 
University of Kansas Medical Center, 3901 Rainbow Blvd. MSN 1032, Kansas City, 
KS 66160. 
 
SUBJECT  RIGHTS AND WITHDRAWAL  FROM THE STUDY 
My and my child's participation in this study is voluntary and the choice to not 
participate or to quit at any time can be made without penalty or loss of benefits. 
Not participating or quitting will have no effect upon the medical care of treatment 
my child receives now or in the future at the University of Kansas Medical center. 
The entire study may be discontinued for any reason without my consent by the 
investigator conducting the study, by the sponsor of the study, or the FDA. My 
child's participation can be discontinued by the investigator or by the sponsor if it 
is felt to be in my child's best interest or if I do not follow the study requirements. If 
I choose to withdraw before my child is 18 months of age, I may be asked to 
answer questions about the study on the telephone. 
 
If I want to cancel permission to use my or my child's health information, I 
should send a written request to Dr. Carlson. The mailing address is Susan 
Carlson, Ph.D., Dept.  of Dietetics and Nutrition, MS 4013, 4019 Delp, University 
of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160. If I 
cancel permission to use my child's health information, the research team will 
stop collecting any additional information about me and my child. 
 
Should the study be terminated prior to the completion of my pregnancy, neither 
the investigator nor the University of Kansas Medical Center will be under any 











Dr. Carlson or her associates have given me information about this research 
study. 
They  have  explained  what  will  be  done  and  how  long  it will  take.They  
explained  the inconvenience, discomfort and risks that may be experienced 
during this study. 
 
By signing this form, I give my permission for my and my child's health 
information to be used and disclosed for the purposes of this research study. If 
I choose not to sign this form, my child and I will not be able to participate in the 
study. 
 
I voluntarily consent to my and my child's participation in this research study. I 
have read the information in this form and have had an opportunity to ask 
questions and have them answered.  I will be given a copy of the signed 
form to keep for my records. 
 
 
Type/Print Subject's IOMe 
 
 
   




Type/Print IOMe of Person Obtaining Consent 
 
  
.  Signature of Person Obtaining Consent Date 
 
 
Type/Print IOMe of Principal Investigator 
 
  
Signature of Principle Investigator Date 
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May the investigators contact you after the study is over to ask if you interested in 
continuing your child's participation? If you agree to be contacted, the investigators 
would explain any new study to you later and you would have the chance to decide 





You may choose not to be contacted in the future and still be able to participate in 




Type/Print Subject's Name 
 
 
   












Type/Print Name of Principal Investigator 
 
  
Signature of Principle Investigator Date 
